We have cloned a cDNA for a novel human homolog of the Drosophila discs large (dlg) tumor suppressor protein, termed NE-dlg (neuronal and endocrine dlg). Northern blot analysis revealed that the gene is highly expressed in neuronal and endocrine tissues. Fluorescence in situ hybridization (FISH) and radiation hybrid mapping studies localized the NE-dlg gene to chromosome Xq13. We also found that the NE-dlg gene encoded a 100 kDa protein. Immunolocalization studies using an NE-dlg antibody showed that the protein tended to be expressed in non-proliferating cells, such as neurons, cells in Langerhans islets of the pancreas, myocytes of the heart muscles, and the prickle and functional layer cells of the esophageal epithelium. Proliferative cells, including various cultured cancer cell lines and basal cells in the esophageal epithelium, showed little expression of the NE-dlg protein. In addition, yeast two-hybrid screening and in vitro binding assays revealed that the NE-dlg interacted with the carboxyl-terminal region of the APC tumor suppressor protein. These data suggest that NE-dlg negatively regulates cell proliferation through its interaction with the APC protein.
Introduction
About 50 tumor suppressor genes in Drosophila have been identi®ed through genetic analysis. Germline mutation in such genes behave as recessive lethals (Gate et al., 1989) . Germline mutations of the lethal (1) discs large 1 (dlg) locus result in imaginal disc neoplasia and a prolonged larval period followed by death (Woods et al., 1989) . The dlg protein includes three copies of the DHR (discs-large homologous region) domain, a SH3 motif, and a domain that is homologous to the yeast guanylate kinase (GUK) (Stehle et al., 1992) . These structures suggest that dlg plays a role in intracellular signal transduction, but there has not yet been any demonstration of its function.
Recently, several genes which encode for polypeptides homologous to the Drosophila dlg have been identi®ed in mammalian cells and categorized in a new protein family termed MAGUK (membrane-associated guanylate kinase homolog) (Woods et al., 1993) . This protein family consists of a human homolog of dlg (hdlg-1) which is homologous to rat SAP-97 (Lue et al., 1994; Muller et al., 1995) , the rat synaptic protein PSD-95/SAP-90 (Cho et al., 1992; Kistner et al., 1993) , the tight junction proteins ZO-1 (Willott et al., 1993) and ZO-2 (Jesaitis et al., 1994; Itoh et al., 1993) , and human erythroid p55 (Ru et al., 1991) . These MAGUK proteins have been shown to localize at the membrane-cytoskeleton interface, and some recently have been reported to bind to membrane associated proteins: hdlg-1/SAP97 interacts with the cytoskeletal protein 4.1 (Lue et al., 1994) and the adenomatous polyposis coli gene (APC) product (Matsumine et al., 1996) , and PSD-95/SAP90 binds to both NMDA receptors (Kornau et al., 1995; Niethammer et al., 1996) and Shaker-type potassium channels (Kim et al., 1995) . Therefore, it is reasonable to speculate that MAGUK proteins have important roles in cellular morphogenesis, adhesion, growth and regulation of ion density by interacting with various key molecules.
In this study, we isolated a new human homolog of the Drosophila dlg gene, which we designated NE-dlg, by combination of computer analysis of the expressed sequenced tag (EST) databases and two-step PCR procedure. We report here the cDNA sequence and chromosome location of this gene, and immunolocalization of the encoded protein using an antibody raised against a unique protein sequence in NE-dlg. Furthermore, we found that NE-dlg interacted with the APC tumor suppressor protein. The biological signi®cance of this gene will be discussed.
Results

Identi®cation of the human gene related to Drosophila dlg and hdlg-1/SAP-97
To identify the human homolog of the Drosophila dlg, we performed sequence database searching using the Blast algorithm. A tblastn search of the Genbank TM database using the dlg and hdlg/SAP-97 peptide sequences revealed that seven EST clones with the accession numbers T31002, M78186, R16282, F08659, F07846, T71695, and T31204 have sequence similarity. Four of these (T31002, M78186, F08659, T31204) were found to be identical to the PSD-95/SAP-90A gene, which had been previously identi®ed (Cho et al., 1992; Kistner et al., 1993) . Two (F07846, T71695) were parts of the p55 gene (Ru et al., 1991) . The sequence of the R16282 EST clone was not found to be identical to any previously reported gene. A 221-bp of R16282 cDNA was ampli®ed by PCR using P1 and P2 primers and a human fetal brain cDNA library. We performed twostep PCR on the ampli®ed cDNA sequence bases to clone the full length cDNA (Figure 1 ).
We identi®ed a 3100-bp cDNA which contains a single large open reading frame encoding a polypeptide of 817 amino acids (Figure 2 ). The nucleotide sequence was con®rmed by sequencing several clones that were generated by independent PCR in order to avoid PCR artifacts. Any dierences in the nucleotide sequence of the various clones were not found. The cDNA was termed NE-dlg. The domain organization characteristic of the other MAGUK family members was also conserved in the NE-dlg polypeptide, with three DHR segments in the N-terminal half of the protein, a central SH3 motif, and a C-terminal GUK domain. Moreover, NE-dlg was found to contain a pair of XPPXY motifs in the amino-terminal region, which shows a signi®cant level of speci®city in binding to a subset of the WW domain that is a structured protein module found in a wide range of regulatory, cytoskeletal, and signaling molecules (Sudol et al., 1995; Williamson, 1994) . This protein showed high similarity to hdlg-1/SAP-97 and Drosophila dlg with 75% and 60% identity, respectively. The three DHR segments have 66% identity to analogous segments in hdlg-1/SAP-97 and 73% to those of rat PSD-95. The SH3 domain was the most similar region between NEdlg and hdlg-1/rat SAP-97 (81% identity). The GUK domain was 39% identical to the protein sequence of yeast GUK and 80% identical to analogous segments in hdlg-1/SAP-97 (Figure 3) . Figure 1 Cloning strategy of the NE-dlg gene. PCR using P1 and P2 primers was performed to amplify a core cDNA fragment (221 bp) from a human fetal brain cDNA library. P3 and P4 primers were designed based on the sequence information of the core cDNA. Ampli®cations of the 5' region (region A) and 3' region (region C) were carried out by the two-step PCR procedure using the fetal brain cDNA library. For ampli®cation of the remaining 5' region (region B), P5 primer was used for the ®rst PCR, and P6 and T3 primers were used for the second PCR. Region A (1.1 kbp) spanned the DHR2 domain to the SH3 motif, region B (1.2 kbp) included the initiating methionine site, and region C (1.4 kbp) spanned the SH3 motif to the C terminal noncoding sequence inclusive of the stop codon Figure 3 Comparison of sequence identities in dlg-related proteins. Protein sequences were compared by Multiple Sequence Alignments at BCM Search Launcher (http://dot.imgen.bcm.tmc. edu:9331/multi-align/multi-align.html). Identical residues are indicated by an asterisk. Domains of DHR1-3, SH3 and GUK are indicated by underlines. The NE-dlg protein showed high similarity to PSD-95/SAP-90 and hdlg-1/SAP-97 with 80% and 75% identity, and moderate similarity to Drosophila dlg, with 60% identity, respectively 
Expression of NE-dlg mRNA in human tissues
To determine the expression pattern of NE-dlg mRNA, we performed Northern blot analysis on various human tissues. NE-dlg transcripts were detected in brain, pancreas, thyroid, trachea and prostate (Figure 4a ). Since this gene was highly expressed in neuronal and endocrine tissues, we designated it as NE-dlg. NE-dlg was expressed in a tissue speci®c manner, whereas the hdlg-1/ SAP-97 was expressed in most of the adult tissues examined. Brain was found to express two species (6.7 and 5.5 kb) of NE-dlg mRNA, and the other tissues expressed two species of mRNA of 5.5 and 4.0 kb. Although the size of the transcript in brain is dierent from that in other tissues, a 2453 bp full-length ORF cDNA fragment of NE-dlg gene could be ampli®ed from RNAs extracted from thyroid and skeletal muscle as well as from brain by RT ± PCR using NED forward and NED reverse primers (Figure 4b ).
Chromosomal localization of NE-dlg
To identify the chromosomal localization of the NE-dlg gene, we performed¯uorescence in situ hybridization (FISH) and PCR mapping using somatic cell hybrid analysis. In the FISH analysis (Figure 5a ), 15 of 50 metaphases examined showed symmetrical double spots on a single chromosome Xq13. All double spots and 75% of the single spots detected were on chromosome Xq13. No spots were found on the Y chromosome. We therefore assigned the NE-dlg gene to chromosome Xq13. Localization was further con®rmed in sequential G-banded chromosomes. In somatic cell hybrid analysis, PCR products of the expected sizes (306 bp) were ampli®ed using S1 and AS1 primers from seven of 24 hybrid cell lines in the monochromosomal somatic cell hybrid DNA panel, and from 16 out of 93 hybrid cell lines in the Genebridge 4 radiation hybrid panel. Comparison with the human chromosomal content of the hybrids, as determined by the manufacturer and the Whitehead Institute/MIT Center for Genome Research, localized the NE-dlg gene to chromosome X and placed it 15.1 cR from GATA64D08 ( Figure 5b) .
Detection of the NE-dlg protein
First, Western blot analysis of COS-7 cells, which were transiently transfected by the HA-tagged NE-dlg expression plasmid (pCGN-NE-dlg), was performed using anti-HA and anti-NE-dlg antibodies. A band of about 100 kDa was detected in lysates of pCGN-NE- dlg transfected COS-7 cells with both anti-HA and anti-NE-dlg antibodies (Figure 6a) , which was very similar to the calculated molecular mass of the fulllength protein encoded by the NE-dlg cDNA. By using the NE-dlg antibody, we performed Western blot analysis to detect the endogenous NE-dlg protein in human and rat brain tissues and rat esophagus tissues. The 100 kDa protein was detected in lysates from human and rat brain tissues and rat esophagus tissues ( Figure 6a ). Most of the NE-dlg protein expressed in the transfected COS-7 cells was found in the 1% Triton X-100 insoluble fraction but not in the soluble fraction ( Figure 6b , lane 1 and 2). However, the endogenous protein was found in both the Triton X-100 soluble and insoluble fractions (Figure 6b , lane 3 and 4). Moreover, we performed Western blot analysis to detect the endogenous NE-dlg protein in various cancer cell lines as shown in Figure 6c . The endogenous NE-dlg protein of 100 kDa was not detected in the lysates from any cell lines examined whereas b-tubulin was found in all samples.
Immunohistochemical analysis of NE-dlg in various tissue sections
To determine the tissue distribution of NE-dlg protein, immunohistochemical analysis using the anti-NE-dlg antibody was performed in various frozen and formalin-®xed paran-embedded tissue sections. Since Northern blot analysis revealed speci®c expression of the NE-dlg transcript in brain and endocrine tissues, we ®rst examined the protein expression in those tissues. In brain, immunoperoxidase staining was seen along the neuronal axon or dendrites in the molecular and the outer granular layers of the cerebral cortex ( Figure  7a ). In pancreas, about half the cells in the Langerhans islets demonstrated dense cytoplasmic staining ( Figure  7b ). However, double immunostaining using an antiinsulin antibody with the anti-NE-dlg antibody suggested that the distribution of NE-dlg positive cells was not the same as that of b and a cells (data not shown). We also examined protein expression in various non-neuronal tissues, including thyroid, gastrointestinal tissues, skeletal muscle, liver, kidney, spleen and lung. NE-dlg was highly expressed in the cytoplasmic region of myocytes of the heart muscle ( Figure 7c ), but it was hardly detected in smooth muscle (data not shown). Cytoplasm of follicular cells in the thyroid were moderately stained (data not shown). Moreover, in strati®ed squamous epithelium, such as the esophagus (Figure 7d ) and tongue, the sites of cell ± cell contact between epithelial cells in the prickle and functional layers, which consist of nonproliferating cells, were strongly stained. However, the basal cell layer, which consisted of proliferative cells, showed no staining.
Detection of an interaction between NE-dlg and APC proteins
To learn about the role of the NE-dlg protein in cells, we used the yeast two-hybrid system for identifying proteins that bind to the NE-dlg protein. An expression vector was constructed by fusing the GAL4 DNA-binding domain to the three DHR regions and SH3 motif of the NE-dlg protein. This bait plasmid was cotransformed in yeast with a prey plasmid containing a human fetal brain cDNA expression library fused to the GAL4 activation domain. We used a system that utilizes GAL4 recognition sites to regulate expression of both HIS3 and LacZ (Durfee et al., 1993) . Colonies were selected that grew on yeast drop-out media lacking Leu, Trp, and His but contained 50 mM 3-amino-1, 2, 4, triazole and that were blue when assayed by X-gal ®lter assay. Ten positive clones were obtained from 5610 5 transformants screened. To con®rm the speci®city of the interactions, the plasmids expressing the activation domain fusion proteins were recovered from the positive clones and cotransformed with GAL4bd-NE- dlg and control baits (Figure 8a ). Three clones were positive in the secondary screening, and all of them contained a 1200 bp insert whose sequence was identical to a part of the adenomatous polyposis coli gene (APC) cDNA sequence. The insert encoded the carboxyl terminal 111-amino acid fragment of the APC tumor suppressor protein (Figure 8b ). To con®rm the interaction between NE-dlg and APC observed in yeast, a fusion protein that contained GST and the three DHR regions and SH3 motif of NE-dlg was expressed in bacteria using the pGEX-2TH expression vector system. Whole cell lysates of human fibrosarcoma HT1080 cells were incubated with either GST or the GST-NE-dlg bound GSH-beads. The binding protein complex was analysed by Western blot using anti-APC antibody, and it showed that APC eciently associated with GST-NE-dlg, but not GST (Figure 8c ).
Discussion
We identi®ed and characterized NE-dlg gene, which is a novel human homolog of Drosophila dlg tumor suppressor gene. While the hdlg-1/SAP-97 transcript, which had been previously identi®ed as another human dlg homolog, was expressed in most human tissues, NE-dlg transcript was abundantly detected in brain and only moderately expressed in endocrine and glandular tissues such as pancreas, thyroid, and trachea.
The NE-dlg protein sequence had high homology to MAGUK protein families. The MAGUK protein families have been shown to interact and/or colocalize with various intracellular molecules, and to be involved in membrane-and cytoskeleton-associated signaling. In the present work, we performed the yeast two-hybrid screening and found that NE-dlg interacted with the carboxyl-terminal region of APC protein.
Matsumine and co-workers reported that the DHR regions of hdlg-1/SAP-97 also interacts with the carboxyl-terminal region of APC (Matsumine et al., 1996) . Since the amino acid sequence of DHR regions in NE-dlg is highly conserved in that of hdlg-1/SAP-97, APC protein may be able to interact with both human dlg homologs. Rat postsynaptic protein (SAP102) was identi®ed recently (Muller et al., 1996; Lau et al., 1996) , and it is likely to be the rat homolog of NE-dlg based on the similarity of reported sequences. SAP102 has been demonstrated to be speci®cally expressed in rat neuronal tissues and to interact with the carboxylterminal tail of the NMDA receptor, to which hdlg-1/ SAP97 also binds. Both APC protein and the NMDA receptor have a threonine (or serine)-X-valine (T/SXV) motif at their carboxyl-terminal end, and this motif has been shown to speci®cally bind to the DHR domains (Kornau et al., 1995; Matsumine et al., 1996; Niethammer et al., 1996) . All these lines of evidence suggest that NE-dlg/SAP102, as well as hdlg-1/SAP97, plays a role in multiple cellular functions such as clustering of NMDA receptors with submembraneous cytomatrix at synaptic junctions in neuronal tissues and regulating cell growth by interacting with APC protein (Kornau et al., 1995; Matsumine et al., 1996; Niethammer et al., 1996) .
Immunolocalization studies using an anti-NE-dlg antibody revealed that the NE-dlg protein is expressed not only in neuronal and endocrine tissues, but also in some non-neuronal tissues. Furthermore, intracellular localization of the protein varied depending on cell types. In the brain, NE-dlg protein was seen along axons and dendrites but not found in cytoplasm of cerebral cortex neurons. In glandular tissues, some populations of islet cells in pancreas and follicular cells in the thyroid were shown to have dense cytoplasmic staining. These distributions of the NE-dlg protein suggest that it may be associated with vesicular transport and the secretion of neurotransmitters and hormones.
In strati®ed squamous epithelium, such as the esophagus and tongue, characteristic expression pattern of NE-dlg protein was observed by immunohistochemical study. The protein was not detected in basal cells, whereas the prickle and functional layer cells highly expressed the protein at sites of cell ± cell contact. Additionally, Western blot analysis demonstrated that the 100 kDa NE-dlg protein was not detected in cultured cancer cell lines which have high proliferative activity. Furthermore, our recent observation revealed that the NEdlg protein was not detected any esophageal cancers, while it was found in the adjacent esophageal epithelium (Morisaki et al., in preparation). These ®ndings provide evidence of a tendency for lower expression of NE-dlg protein in proliferative cells and higher expression in non-proliferative cells, suggesting that the NE-dlg expression negatively regulates cell growth.
The molecular mechanism of the tumor suppressor eect of APC is still obscure. However, recent reports suggested that APC protein interacts with b-catenin (Rubinfeld et al., 1993; Su et al., 1993) and this binding may inhibit b-catenin-induced transcriptional activity, resulting in growth suppression . Furthermore, expression of wild-type APC has been demonstrated to induce apoptosis in APC mutated colorectal epithelial cells (Morin et al., 1996) . These observations indicate that APC could modulate cadherin-catenin mediated cell adhesion signals and consequently control cell growth and the cell death process. Previous reports showed that most of the APC gene mutations in tumor cells result in premature translational termination and thereby produce truncated APC proteins lacking their C-terminal regions. Therefore, it is conceivable that the APC mutations impair the APC-NE-dlg complex formation and may consequently lead to development of tumors. This could provide hypothesis that mutation of the NE-dlg gene also impairs the complex formation without APC mutation and results in tumorigenesis. Therefore, the location of the NE-dlg gene on the chromosome Xq13 region can be a potential site for a tumor suppressor gene. Although major genetic alterations including large deletions, translocations or ampli®cation, of this region have not been reported in any cancers, recent observations and the pattern of familial transmission of prostate cancer in men is consistent with an X-linked or recessive genetic model of inheritance supports a role of the X chromosome in the development of certain cancers (Monroe et al., 1995) . Further experiments to detect alterations of the NE-dlg gene in various inherited and sporadic cancers will be required to demonstrate that it acts as a tumor suppressor gene.
Drosophila has been analysed to have over 50 genes whose mutation results in hyperplasia or neoplastic overgrowth in various tissues. More than 20 of them have been cloned and characterized, and some have been identi®ed their mammalian homologs (Watson et al., 1994) . Our ®ndings demonstrated that a human dlg homolog, like the Drosophila dlg, is also involved in cell proliferative control and tumor suppression. Accordingly, identifying and characterizing human homologs of Drosophila tumor suppressor genes potentially provides an alternative approach to ®nding novel tumor suppressor genes whose loss-of-function leads to development of human tumors. Materials and methods
EST database screening and PCR-based full length cDNA cloning
We searched for human homologs of the dlg gene by scanning a database of human genes identi®ed by the expressed sequence tag (EST) method using tblastn (Adams et al., 1991; Altschul et al., 1990) . The sequence information of the clone R16282 obtained from EST allowed the synthesis of a pair of speci®c primers, P1 (5'-TCGGAAGATCAAGGTCATCATTGA-3') and P2 (5'-TGAGTGGTGGCAGGCAAGGCTGGT-3'). PCR using the P1 and P2 primers were performed to amplify a core cDNA fragment from a lZAP human fetal brain cDNA library (Stratagene). The core 221 bp sequence was obtained from the PCR product and subcloned into a pCRII TA cloning vector (Invitrogen). Two primers, P3 (5'-CAGGTTCTTTGCTTCCATAATA-3') and P4 (5'-AC-ACGGAGAAAGTGAGCAGATCGG-3') were designed based on the sequence information of the core 221-bp cDNA. Ampli®cation of the 5' region was carried out by the twostep PCR procedure using rTth DNA polymerase (Perkin Elmer) which has proof reading activity. The ®rst PCR was performed for 50 cycles using only P1 primer to amplify single strand cDNA in a 15 ml reaction volume containing the fetal brain cDNA library as a template. Each cycle consisted of denaturation at 948C for 30 s, annealing at 608C for 30 s, and extension at 728C for 90 s. The ®rst PCR product was used as a template in the second run, where P3 and T3 (5'-ATTAACCCTCACTAAAG-3') were utilized as primers to amplify the 5' region cDNA. PCR was performed for 40 cycles of denaturation at 948C for 30 s, annealing at 608C for 30 s, and extension at 728C for 60 s. Ampli®cations of the 3' region and the remaining 5' region were also performed by the same two-step PCR as described above.
For the 3' region ampli®cation, P2 was used for the ®rst round PCR, and P4 and T7 (5'-AATACGACTCACTATAG-3') were used for the second round PCR. For ampli®cation of the remaining 5' region, P5 (5'-GTTGTCTCCTGGGA-TGTGCTGGTTG-3') was used for the ®rst PCR, and P6 (5'-GAAACCCAGGCCTTTGGGCCCTTTG-3') and T3 were used for the second PCR. The PCR fragments were ligated into a pCRII TA cloning vector and sequenced. DNA sequencing of double-stranded plasmid DNAs was performed with 373S DNA sequencer (Applied Biosystems) using standard protocols. The nucleotide sequence was con®rmed by sequencing several clones (more than three) that were generated by independent PCR to avoid errors introduced during the PCR reaction. DNA and protein sequence were compared by the basic local alignment search tool (BLAST) network service at the National Center for Biotechnology Information (NCBI).
Northern blot analysis
Northern blot derived from multiple human tissues and cancer cell lines containing 2 mg of poly(A) + RNA per lane were obtained from Clontech. The membranes were probed with a 1.4 kbp cDNA fragment of NE-dlg, a 1.1 kbp cDNA fragment of hdlg-1/SAP-97 and a 2.0 kbp human bactin cDNA that had been labeled with [a- 32 P]dCTP by random-primed labeling. The membranes were exposed to X-ray ®lm with an intensifying screen for 3 days at 7708C.
FISH
A 1.7 Kb cDNA fragment of human NE-dlg (n.t. 217 ± 1991) was used as a probe for FISH analysis. The probe was biotin-labeled, ethanol precipitated with human placental DNA and salmon sperm DNA, and resuspended in hybridization solution (50% formamide/26SSC/10% dextran sulfate). Chromosome slides were prepared from PHAstimulated female peripheral lymphocyte cultures treated with thymidine synchronization and bromodeoxyuridine. Direct R-banding FISH followed by G-banding with Wright Giemsa staining was performed as described in detail elsewhere (Kuwano et al., 1991) . In the brief, slide was stained with Hoechst 33258 mounted in 26SSC, exposed to a black lamp at 758C, denatured, preassociated for 30 min at 378C, and in situ hybridized. After detection using¯uorescein-labeled avidin, slides were mounted in 0.7 mg/ml propidium iodine and analysed with a Nikon Opitiphoto-2 (Nikon, Japan) and Nikon ®lter combination B-2A (excitation at 450 ± 490 nm). The photographs were taken with Ektachrome ASA 100 ®lm (Kodak). The slide was then desalted, immersed in borate buer, and stained in a mixture of Wright's Giemsa solution and borate buer.
PCR mapping of NE-dlg gene
PCR was performed to detect NE-dlg sequences in the Monochromosomal somatic cell hybrid DNA panel (UK HGMP Resource Center) and in the Genebridge 4 Radiation Hybrid Screening Panel (Research Genetics, Inc) using a set of primers (S-1 : 5'-TGAGTGGTGGCA-GGCAAGGCTGGT-3' and AS-1 : 5'-TGGAATCAGAAA-GAAGTCCTGTTA-3') which were designed based on a partial genomic sequence of the NE-dlg gene. The S-1 and AS-1 primers were expected to amplify a 306 bp PCR product from human genomic DNA as a template. PCR was carried out in a 15ml reaction volume for 35 cycles. Each cycle consisted of denaturation at 958C for 30 s, annealing at 608C for 30 s, extension at 728C for 30 s, and 5ml of each reaction was analysed by electrophoresis through a 2.0% agarose gel run in TAE buer.
The PCR results of the Radiation Hybrid Panel were sent to the Whitehead Institute/MIT Center for Genome Research via WWW (http://www-genome.wi.mit.edu/) for mapping of the genes relative to the radiattion hybrid map of the human genome (Hudson et al., 1995) .
Production of anti-NE-dlg polyclonal antibody
Antibody against a unique protein sequence in NE-dlg was raised by the subcutaneous immunization of rabbits with a synthetic peptide (VKFHARTGMIESNRDFPLSDDYY-GAKN) which was coupled to KLH. The antibody was anity-puri®ed on a column containing the peptide crosslinked to sepharose.
Construction of the NE-dlg expression vector
The full length ORF of the NE-dlg cDNA (2453 bp) was ampli®ed by PCR from the lZAP human fetal brain cDNA library by the primer NED forward (5'-CCGCGTCT-AGAAGTGCCATGCACAAGCACCAGCACTG CTG-3') containing a XbaI site (underlined) and the primer NED reverse (5'-ATGGTGTCGACGGTACCTTCAGAGTTT-TTCAGGGGATGGGAC-3') containing a KpnI site (underlined). Cycling reactions were performed in a 25 ml reaction volume for 40 cycles using rTth DNA polymerase. Each cycle consisted of denaturation at 948C for 1 min, annealing at 608C for 1 min, and extension at 728C for 2 min. The PCR fragments were digested with XbaI and KpnI, and ligated into a pCGN expression vector. To express HA epitope-tagged NE-dlg, the pCGN-NE-dlg was transfected into COS-7 cells by the liposome-mediated gene transfer method (Felgner et al., 1987) .
Western blotting
For Western blotting, samples containing equal amounts of protein (15 mg) from lysates of cultured cells and frozen tissues were separated on an 8% polyacrylamide gel and transferred to a nitrocellulose ®lter with a constant current of 140 mA for 2 h. The ®lters were blocked overnight at 48C with PBS containing 10% skim milk and then incubated with 1 : 1000 diluted anti-HA antibody (12CA5), 1 : 500 diluted anti-NE-dlg antibody and 1 : 10000 diluted anti-b-tubulin antibody (CHEMICON) in PBS containing 0.03% Tween 20 for 2 h, and washed two times for 7 min each time with PBS containing 0.3% Tween 20. The ®lters were then incubated with horseradish peroxidase-conjugated anti-mouse IgG antibody for anti-HA and anti-b-tubulin antibodies and anti-rabbit IgG antibody for anti-NE-dlg antibody (Amersham) for 40 min, and speci®c proteins were detected using an enhanced chemiluminescence system (Amersham).
Immunohistochemical analysis
Formalin-®xed, paran-embedded tissues were cut into sections 4 mm thick, deparanized and rehydrated. Frozen tissue sections were cut into sections 6 mm thick and ®xed in 10% buered formalin for 15 min. After ®xation, the slides were rinsed in PBS. Endogenous peroxidase was inhibited by treatment with 0.3% H 2 O 2 in methanol for 15 min. Immunoperoxidase staining was performed with an avidin-biotin kit (Vector, Burlingame, CA). Nonspeci®c staining was blocked using normal goat serum. After shaking o the serum, the slides were treated by primary antibody (2 mg/ml) in PBS for 1 h. They were washed with PBS and then incubated with secondary biotinylated antirabbit immunoglobulin antibody for 30 min and avidin:biotin-conjugated horseradish peroxidase for 30 min, with rinses in PBS between each step. The peroxidase substrate, 3.3'-diaminobenzidine tetrahydrochloride (DAB: 3 mg in 10 ml of 0.05 M Tris-HCl, pH 7.6, in 0.01% hydrogen peroxide), was added, and the peroxidase reaction was allowed to continue for 5 min at room temperature. Excess DAB was then washed o for 5 min, and the slides were counterstained in hematoxylin, and mounted with Crystal/Mount (Biomeda).
Yeast two-hybrid screening
The partial NE-dlg cDNA, which included three DHR repeats and the SH3 region, was obtained by PCR using a set of primers (5'-GTGATCATATGTTCAAATATGAG-GAAATCGT-3' and 5'-CATCCGGATCCAAGCTTGGA-ACTTCACAGTTTTCAATCGAGC-3') containing NdeI and BamHI cloning sites (underlined), respectively. The PCR product was double digested with NdeI and BamHI and subcloned into the pAS1-CYH2 vector as a fusion to the CAL4 DNA-binding domain. The resultant plasmid, pGAL4bd-NE-dlg was cotransformed with a prey plasmid containing a human fetal brain cDNA library fused to the GAL4 activation domain (GAL4ad) in the pGAD10 vector (Clontech) by elecroporation. The transformants (5610 5 ) were screened with streaking on selection medium (SD-Trp, -Leu and -His) followed by b-galactosidase ®lter assay. The pGAD10 plasmids containing the inserted cDNA were recovered from the positive clones and cotransformed with pGAL4bd-NE-dlg or control baits to con®rm their interaction. DNA sequencing of the cDNA inserted into the positive plasmid was performed by the dideoxynucleotide chain termination method.
Construction of GST fusion protein and in vitro binding assay
The NE-dlg cDNA fragment used in the pGAL4-bd-NEdlg plasmid was subcloned into a pGEX-2TH bacterial expression vector. Expression and puri®cation of the GST-NE-dlg protein were performed as described previously (Takeshima et al., 1994) . Human ®brosarcoma HT1080 cells were lysed with TNT buer (50 mM Tris-HCl pH 7.4, 150 mM NaCl and 0.5% Triton X-100) containing 1 mM phenylmethylsulfonyl¯uoride (PMSF), 10 mg/ml leupeptin, 1.5 mM pepstatin, 3% aprotinin, and 1 mM sodium orthovanadate, and the lysate was incubated with either GST or the GST-NE-dlg fusion protein immobilized on glutathion-agarose beads (GSH-beads) for 1 h at 48C. The beads were then washed with TNT buer and heated in Laemmlis' sample buer (Laemmli, 1970) at 1008C for 5 min. The samples were resolved by SDS ± PAGE and transferred onto a nitrocellulose membrane, and detected by anti-APC antibody (Ab-2: Oncogene Science, Inc).
